91 related articles for article (PubMed ID: 8859227)
1. Host genetic and adjuvant factors influence epitope specificity to a major recombinant grass allergen.
Yang M; Wang YY; Zhang L; Chong P; Mohapatra SS
Int Arch Allergy Immunol; 1996 Oct; 111(2):173-81. PubMed ID: 8859227
[TBL] [Abstract][Full Text] [Related]
2. Antibody responses to bee melittin (Api m 4) and hornet antigen 5 (Dol m 5) in mice treated with the dominant T-cell epitope peptides.
King TP; Lu G; Agosto H
J Allergy Clin Immunol; 1998 Mar; 101(3):397-403. PubMed ID: 9525458
[TBL] [Abstract][Full Text] [Related]
3. Multiple B- and T-cell epitopes on a major allergen of Kentucky Bluegrass pollen.
Zhang L; Yang M; Chong P; Mohapatra SS
Immunology; 1996 Feb; 87(2):283-90. PubMed ID: 8698392
[TBL] [Abstract][Full Text] [Related]
4. Antigen- and isotype-specific immune responses to a recombinant antigen-allergen chimeric (RAAC) protein.
Zhang L; Mohapatra SS
J Immunol; 1993 Jul; 151(2):791-9. PubMed ID: 8335908
[TBL] [Abstract][Full Text] [Related]
5. The allergy adjuvant effect of particles - genetic factors influence antibody and cytokine responses.
Nygaard UC; Aase A; Løvik M
BMC Immunol; 2005 Jun; 6():11. PubMed ID: 15967044
[TBL] [Abstract][Full Text] [Related]
6. Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice.
Wiedermann U; Herz U; Baier K; Vrtala S; Neuhaus-Steinmetz U; Bohle B; Dekan G; Renz H; Ebner C; Valenta R; Kraft D
Int Arch Allergy Immunol; 2001 Sep; 126(1):68-77. PubMed ID: 11641608
[TBL] [Abstract][Full Text] [Related]
7. Allergenic and antigenic determinants of latex allergen Hev b 1: peptide mapping of epitopes recognized by human, murine and rabbit antibodies.
Chen Z; Van Kampen V; Raulf-Heimsoth M; Baur X
Clin Exp Allergy; 1996 Apr; 26(4):406-15. PubMed ID: 8732237
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and tolerogenicity of a major house dust mite allergen, Der p I from Dermatophagoides pteronyssinus, in mice and rats.
Stewart GA; Holt PG
Int Arch Allergy Appl Immunol; 1987; 83(1):44-51. PubMed ID: 3570526
[TBL] [Abstract][Full Text] [Related]
9. Mouse strain specificity of the IgE response to the major allergens of Phleum pratense.
Seitzer U; Bussler H; Kullmann B; Petersen A; Becker WM; Ahmed J
Int Arch Allergy Immunol; 2005 Apr; 136(4):347-55. PubMed ID: 15741733
[TBL] [Abstract][Full Text] [Related]
10. Induction of IgE responses using a recombinant mosquito salivary allergen rAed a 2 without adjuvant in mice.
Wang H; Mao X; Simons FE; Peng Z
Int Arch Allergy Immunol; 1999 Oct; 120(2):135-40. PubMed ID: 10545767
[TBL] [Abstract][Full Text] [Related]
11. A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination.
Linhart B; Hartl A; Jahn-Schmid B; Verdino P; Keller W; Krauth MT; Valent P; Horak F; Wiedermann U; Thalhamer J; Ebner C; Kraft D; Valenta R
J Allergy Clin Immunol; 2005 May; 115(5):1010-6. PubMed ID: 15867859
[TBL] [Abstract][Full Text] [Related]
12. Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination.
Focke M; Mahler V; Ball T; Sperr WR; Majlesi Y; Valent P; Kraft D; Valenta R
FASEB J; 2001 Sep; 15(11):2042-4. PubMed ID: 11511525
[TBL] [Abstract][Full Text] [Related]
13. Immunoregulatory role of Ig isotypes. I. Induction of contrasuppressor T cells for contact sensitivity responses by antibodies of the IgM, IgG1, and IgG3 isotypes.
Ptak W; Flood PM; Janeway CA; Marcinkiewicz J; Green DR
J Immunol; 1988 Aug; 141(3):756-64. PubMed ID: 2456332
[TBL] [Abstract][Full Text] [Related]
14. Recombinant allergens and diagnosis of grass pollen allergy.
Olsen E; Mohapatra SS
Ann Allergy; 1994 Jun; 72(6):499-506. PubMed ID: 7515604
[TBL] [Abstract][Full Text] [Related]
15. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov AA; Almo SC; Valenta R
Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
[TBL] [Abstract][Full Text] [Related]
16. An alternative allergen:adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for treatment of grass-pollen allergy.
Rask C; Lund L; Lund G; Heydenreich B; Wurtzen P; Bellinghausen I; Saloga J; Lund K
Clin Exp Allergy; 2012 Sep; 42(9):1356-68. PubMed ID: 22925322
[TBL] [Abstract][Full Text] [Related]
17. A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy.
Kussebi F; Karamloo F; Rhyner C; Schmid-Grendelmeier P; Salagianni M; Mannhart C; Akdis M; Soldatova L; Markovic-Housley Z; Von Beust BR; Kündig T; Kemeny DM; Blaser K; Crameri R; Akdis CA
J Allergy Clin Immunol; 2005 Feb; 115(2):323-9. PubMed ID: 15696088
[TBL] [Abstract][Full Text] [Related]
18. Liposome-entrapped T-cell peptide provides help for a co-entrapped B-cell peptide to overcome genetic restriction in mice and induce immunological memory.
Gregoriadis G; Wang Z; Barenholz Y; Francis MJ
Immunology; 1993 Dec; 80(4):535-40. PubMed ID: 7508417
[TBL] [Abstract][Full Text] [Related]
19. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.
Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R
Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924
[TBL] [Abstract][Full Text] [Related]
20. Lipocalin allergen Bos d 2 is a weak immunogen.
Saarelainen S; Zeiler T; Rautiainen J; Närvänen A; Rytkönen-Nissinen M; Mäntyjärvi R; Vilja P; Virtanen T
Int Immunol; 2002 Apr; 14(4):401-9. PubMed ID: 11934876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
